As the new Congress and a new administration start up, the fate of FDA-issued regulations on laboratory-developed tests (LDTs ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that leave minority patients at a disadvantage due to their under-representation in ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

The funding includes $11.7 million from the National Institutes of Health and matched dollar-by-dollar by UofL.

For the first two to three weeks of their lives, infants have to undergo screening for neonatal jaundice (NNJ). It typically ...

A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...